Satomi Tomida

Dr. Satomi Tomida


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
STSatomi Tomida
Satomi Tomida
DGDayan B. Goodenowe
Dayan B. Goodenowe
TKTeruhide Koyama
Teruhide Koyama
EOEtsuko Ozaki
Etsuko Ozaki
NKNagato Kuriyama
Nagato Kuriyama
TTTetsuya Taguchi
Tetsuya Taguchi
The polyunsaturated fatty acid (PUFA) elongase, ELOVL5, is upregulated in breast cancer (BC) vs. adjacent normal tissue. We performed a comprehensive lipid metabolomic analysis of serum using high-resolution accurate mass spectrometry from two case-control studies that included non-BC, BC subjects pre-surgery, and BC subjects one-month post-surgery to determine if the metabolic signatures of over-active fatty acid elongation and other lipid changes could be detected in BC vs. non-BC subjects: study 1 (n = 48: non-BC, n = 69: pre-surgery BC); study 2 (blinded validation: n = 121: non-BC, n = 62: pre-surgery BC, n = 31: one month post-surgery). The ratio of the ELOVL5 precursor, linoleic acid (18:2) to a non-ELOVL5 precursor, oleic acid (18:1) was evaluated in multiple lipid pools (phosphatidylethanolamine (PtdEtn), phosphatidylcholine (PtdCho), lyso-PtdCho, and free fatty acids). This ratio was lower in pre-surgery BC subjects in all pools in both studies (p < 0.001). At one-month post-surgery, the 18:2/18:1 ratios increased vs. pre-surgery and were no longer different from non-BC subjects (p > 0.05 expect for lyso-PtdCho). In contrast to the elongation biomarkers, docosahexaenoic acid (22:6n-3) containing ethanolamine plasmalogen (EtnPls) species were observed to be further decreased in BC subjects one-month post-surgery vs. pre-surgery levels (p < 0.001). These results are consistent with the hypothesis that ELOVL5 is upregulated in BC tissue, which would result in the selective depletion of 18:2 vs. 18:1 containing lipid species. Surgical removal of the tumor removes the overactive ELOVL5 effect on serum lipids. In contrast, the low EtnPls levels do not appear to be caused by BC tumor activity and may be pre-existent and a possible risk factor for BC. These results indicate that it may be possible to screen for both breast cancer risk and breast cancer activity using a simple blood test.

23 November 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
EOEtsuko Ozaki
Etsuko Ozaki
DMDaisuke Matsui
Daisuke Matsui
NKNagato Kuriyama
Nagato Kuriyama
STSatomi Tomida
Satomi Tomida
YNYukiko Nukaya
Yukiko Nukaya
TKTeruhide Koyama
Teruhide Koyama
There are many reports on the risk of falls in older adults but none regarding the risk among middle-aged people. We aimed to determine fall risk factors among middle-aged women. The participants comprised 1421 women aged 40 to 64 years; anthropometric and other measurements were obtained, and lifestyle factors were examined using a self-administered questionnaire. The participants were categorized into two groups (No-fall and Fall/Almost-fall) based on their questionnaire responses. The No-fall and Fall/Almost-fall groups comprised 1114 and 307 participants, respectively. Body mass index, abdominal circumference measurements, and prevalence of dyslipidemia were significantly higher in the Fall/Almost-fall group. Additionally, those in the Fall/Almost-fall group had a shorter two-step test, experienced difficulty performing the 40 cm single-leg sit-to-stand test, and had higher 25-question Geriatric Locomotive Function Scale (GLFS-25) scores than those in the No-fall group. The results of the adjusted logistic regression analysis indicated that physical activity, higher GLFS-25 scores, and sedentary time of more than seven hours were all risk factors for falling or almost falling. Longer sedentary time is a new risk factor for falls among middle-aged women. It is necessary for people to be concerned with their sedentary behavior, such as by reducing or interrupting continuous sedentary time.

7 March 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
RHReisa Hiramatsu
Reisa Hiramatsu
EOEtsuko Ozaki
Etsuko Ozaki
STSatomi Tomida
Satomi Tomida
TKTeruhide Koyama
Teruhide Koyama
Background: Eating speed has been implicated as a leading cause of metabolic syndrome (MetS). However, it is difficult to break the habit of eating fast. Since coffee consumption is associated with a lower risk of MetS, we investigated the association between eating speed and the amount of coffee consumed with MetS. Methods: This study included data from 3881 participants (2498 females and 1383 males). We used a self-administered questionnaire to collect information on participants’ coffee consumption (<1 cup/day and ≥1 cup/day) and eating speed (slow, normal, or fast). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression analyses to investigate the relationship between the prevalence of MetS due to eating speed and the amount of coffee consumed. Results: The group that consumed ≥1 cup/day of coffee (filtered or instant) had a lower OR for MetS compared to the group that consumed <1 cup/day (OR: 0.695; 95% Cl: 0.570–0.847). The eating fast group, compared to the eating slow group, had a higher OR for MetS (OR: 1.689; 95% Cl: 1.227–2.324). When the data were stratified by coffee consumption and eating speed groups, the slow-eating group among those who consumed <1 cup/day of coffee (filtered or instant) had a lower OR for MetS (OR: 0.502; 95% CI: 0.296–0.851) compared to the fast-eating group. In contrast, the groups who consumed ≥1 cup/day of coffee were associated with lower OR for MetS, regardless of their eating speed. Conclusions: This suggests that drinking ≥1 cup/day of coffee may help prevent MetS induced by eating fast.